Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on PK of ACT-541468 in Healthy Males
NCT03799978Phase 1Completed
- Sponsor
- Idorsia
- Start
- Mar 2019
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of daridorexant in Insomnia (2 arms), sponsored by Idorsia. Primary endpoint: Area under the plasma concentration-time curve from time zero to 24 hours. Started Mar 2019; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03799978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03799978.